Over the years many scientists who have become involved in bioinformatics have learned from peers and through self-study. But with a growing number of options for a formal bioinformatics education, as well as an informal education through non-traditional resources, such as blogs, industry pros are offering tips on the many ways researchers can expand their knowledge.

Amid mounting industry dissatisfaction with newly issued Medicare reimbursement levels for molecular tests, a diverse group of stakeholders have formed a coalition hoping that collectively they can sway the Centers for Medicare & Medicaid Services to make the price-setting pr

Originally published July 30.

Cigna announced last week that it will require its members to undergo genetic counseling before deciding to cover genetic testing for heightened risk of breast cancer, colorectal cancer syndromes, or Long QT syndrome.

Based on promising results from a late-stage trial, Vertex Pharmaceuticals is hoping to expand the indication of its cystic fibrosis drug Kalydeco (ivacaftor) in other genetically defined patient populations.

With Exclusive Rights, MolecularMD Developing Dx to Advance Squamous Cell Lung Cancer Treatments

ARCA Biopharma, a firm developing genetically targeted treatments for cardiovascular diseases, has appointed Ray Woosley to its board of directors.

In Genome Biology this week: microRNA signature of Alzheimer's disease, very long intergenic, non-coding RNAs, and more.

This story was originally published July 25. Despite a 91 percent increase in revenues in the second quarter, Sequenom said today that changes to how molecular diagnostic tests are coded and billed are impacting its ability to get reimbursed.

Researchers from Dennis Lo's lab at The Chinese University of Hong Kong have adapted their non-invasive prenatal sequencing method for bisulfite sequencing to analyze the methylation status of fetal DNA in maternal plasma samples.

In an attempt to establish standards and consistency in the growing field of clinical next-generation sequencing, a workgroup for the American College of Medical Genetics and Genomics last week published guidelines in

Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia. Opatz S, Polzer H, Herold T, Konstandin NP, Ksienzyk B, Zellmeier E, et al.

Trovagene's stockholders have approved all six of the nominees for its board of directors, all of whom are current directors, to serve until the 2014 annual stockholder meeting.

The Wellcome Trust Sanger Institute has released version 66 of

NEW YORK (GenomeWeb News) – Cellular Dynamics International said on Tuesday that it has closed its initial public offering, raising net proceeds of about $43 million.

The story has been updated to include comments from Qiagen's conference call this morning.

NEW YORK (GenomeWeb News) – Fluidigm and Olink Bioscience today announced a co-marketing deal that combines each other's technologies to enable the interrogation of 96 samples across 92 proteins in one run from one microliter of sample in less than one day.

NEW YORK (GenomeWeb News) – Life Technologies today said that it has signed an agreement to supply Novartis with its Dynabeads for use in immunotherapeutics being developed by the drug firm for cancer.

NEW YORK (GenomeWeb News) – Quidel reported after the close of the market Tuesday that its second-quarter revenues declined 4 percent year over year, due primarily to lower sales of its infectious disease diagnostic products.

NEW YORK (GenomeWeb News) – The National Institutes of Health plans to renew a program that will fund collaborative translational research projects engaging extramural researchers and intramural investigators that will use the resources available through the NIH Clinical Center.

Luminex reported a 12 percent increase in second-quarter revenues this week, driven largely by a 24 percent spike in assay sales.

Illumina's microarray business continued to grow in the second quarter, with customer demand for its Omni and Core families of genotyping arrays, contributions from recent addition BlueGnome, and sales to direct-to-consumer genetics firms such as 23andMe and Ancestry.com pushing

A quartet of recent papers authored by geneticists at Birmingham Women's Hospital has shed greater light on the application of chromosomal microarrays in prenatal diagnostics in the UK.

Development of a suspension microarray for the genotyping of African Swine Fever Virus targeting the SNPs in the C-terminal end of the p72 gene region of the genome.

Panasonic has received US Patent No. 8,496,794, "Biosensor, biosensor chip, and biosensor device." The described platform can electronically detect the binding reaction of a biological substance such as an oligonucleotide, antigen, enzyme, peptide, antibody, or glucose.